RxDoctor Payments Data

Jordan Wong, DO

Family Medicine · Smithfield, NCNPI 1255950465

Payments from drug & device makers

$1,731in general payments, 2019–2025

Across 86 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$365
  • AbbVie$321
  • AstraZeneca$278
  • Boehringer Ingelheim$166
  • Lilly USA, LLC$163
  • UCB, Inc.$115
  • plus $323 from 11 others

What the payments were for

  • Food & beverage$1,71199%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,731 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$47,896
Medicare patients
123
Services billed
685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin76$84,649
OzempicSemaglutide56$75,959
EliquisApixaban53$39,781
RybelsusSemaglutide22$36,991
MounjaroTirzepatide35$36,188
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$26,343
LinzessLinaclotide35$24,988
Tresiba Flextouch U-100Insulin Degludec14$17,160
XareltoRivaroxaban18$15,085
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr30$14,955
JanuviaSitagliptin Phosphate13$14,733
MyrbetriqMirabegron14$7,660
SymbicortBudesonide/Formoterol Fumarate31$7,476
Humalog Kwikpen U-100Insulin Lispro20$6,638
Atrovent HfaIpratropium Bromide11$5,196

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$365$112,95078 claims
Boehringer IngelheimJardiance$166$84,64976 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$22$46,16682 claims
PfizerEliquis$31$39,78153 claims
Lilly USA, LLCMounjaro$163$36,18835 claims
AbbVieLinzess, Synthroid$321$26,74649 claims
MerckJanuvia$16$14,73313 claims
AstraZenecaSymbicort$278$7,47631 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Smithfield

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →